Sponsor:
Stanford University
Code:
NCT07916324
Conditions
Scleroderma
Sclerodactyly
Systemic Sclerosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
hyaluronidase
Brief summary:
Conditions
Scleroderma
Sclerodactyly
Systemic Sclerosis
Study ID
NCT07916324
Start date
Dec 1, 2026
Status verified date
Nov, 2026
Completion date
Dec, 2027
Anticipated
Primary completion date
Sep, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
10 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Arm Title: Left Hand Hyaluronidase, Right Hand Control
experimental: Right Hand Hyaluronidase, Left Hand Control
Interventions
hyaluronidase
Primary outcome measure
Central contacts
Locations
Stanford University
Recruiting
Stanford, California, United States, 94305
Sponsor
Stanford University
Last update posted
Nov 19, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-20. This information was provided to ClinicalTrials.gov by Stanford University on 2026-11-19. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.